Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Kramer

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Pediatric Infectious Disease|January 1, 1984
Antimicrobial therapy of febrile children with malignancies and possible sepsisJ P Frazier, W G Kramer, L K Pickering, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacodynamics of torsemide in patients with congestive heart failureD Vargo, W G Kramer, P K Black, et al.
Journal of Clinical Pharmacology|July 1, 1978
The pharmacokinetics of bleomycin in manW G Kramer, S Feldman, A Broughton, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Amikacin pharmacokinetics in pediatric patients with malignancyT G Cleary, L K Pickering, W G Kramer, et al.
Journal of Clinical Pharmacology|July 1, 1988
Pharmacokinetics and bioavailability of dilevalol in normotensive volunteersW G Kramer, N Nagabhushan, M B Affrime, et al.
Clinical Pharmacology and Therapeutics|June 1, 1995
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failureD L Vargo, W G Kramer, P K Black, et al.
Aviation, Space, and Environmental Medicine|November 1, 1983
Pharmacokinetics of pentobarbital under hyperbaric and hyperbaric hyperoxic conditions in the dogW G Kramer, D W Welch, W P Fife, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiencyT W Gehr, D W Rudy, G R Matzke, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiencyD W Rudy, T W Gehr, G R Matzke, et al.
Transplantation|April 1, 1986
Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassayB D Kahan, W G Kramer, C Wideman, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Pediatric Infectious Disease|January 1, 1984
Antimicrobial therapy of febrile children with malignancies and possible sepsisJ P Frazier, W G Kramer, L K Pickering, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacodynamics of torsemide in patients with congestive heart failureD Vargo, W G Kramer, P K Black, et al.
Journal of Clinical Pharmacology|July 1, 1978
The pharmacokinetics of bleomycin in manW G Kramer, S Feldman, A Broughton, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Amikacin pharmacokinetics in pediatric patients with malignancyT G Cleary, L K Pickering, W G Kramer, et al.
Journal of Clinical Pharmacology|July 1, 1988
Pharmacokinetics and bioavailability of dilevalol in normotensive volunteersW G Kramer, N Nagabhushan, M B Affrime, et al.
Clinical Pharmacology and Therapeutics|June 1, 1995
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failureD L Vargo, W G Kramer, P K Black, et al.
Aviation, Space, and Environmental Medicine|November 1, 1983
Pharmacokinetics of pentobarbital under hyperbaric and hyperbaric hyperoxic conditions in the dogW G Kramer, D W Welch, W P Fife, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiencyT W Gehr, D W Rudy, G R Matzke, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiencyD W Rudy, T W Gehr, G R Matzke, et al.
Transplantation|April 1, 1986
Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassayB D Kahan, W G Kramer, C Wideman, et al.
Pageof 6